Thursday, June 3, 2010
Although a growing number of
universities and research centers are taking steps to incubate translatable
early-stage research,1,2 the vast majority of institutions have yet
to address the gap that exists between their discoveries and the further
development required before a biotech or pharma gets interested. U.K.-based TPP Global Development Ltd.
is hoping to play the role of middleman for such institutions.
S. SciBX 3(22); doi:10.1038/scibx.2010.664
Published online June 3, 2010
1. Edelson, S. SciBX 2(20);
2. Osherovich, L. SciBX
COMPANIES AND INSTITUTIONS MENTIONED
Institute of Technology, Cambridge, Mass.
TPP Global Development Ltd.,